# Clinical Trial Serious Adverse Event Reporting

A blockchain-based research safety platform for identifying serious adverse events, coordinating expedited reporting, and ensuring regulatory compliance in clinical trials.

## Overview

This smart contract system provides a transparent and immutable platform for managing serious adverse event (SAE) reporting in clinical trials. It enables research teams to identify SAEs, assess causality, prepare expedited reports, notify sponsors, and ensure timely regulatory submission according to FDA, EMA, and ICH-GCP guidelines.

## Features

### Event Identification
- **Automatic SAE Detection**: Flag events meeting serious criteria
- **Severity Classification**: Categorize event seriousness and severity
- **Expectedness Assessment**: Compare against known adverse reactions
- **Real-Time Alerting**: Immediate notification of serious events
- **Multi-Site Coordination**: Track events across trial locations

### Causality Assessment
- **Relationship Evaluation**: Assess relationship to investigational product
- **Naranjo Scale Integration**: Standardized causality assessment
- **Medical Review**: Document physician causality determinations
- **Alternative Etiology**: Track confounding factors and alternative causes
- **Challenge/Rechallenge**: Document re-exposure outcomes

### Expedited Reporting
- **Timeline Management**: Track regulatory reporting deadlines
- **Report Generation**: Automated CIOMS form preparation
- **Sponsor Notification**: Immediate sponsor alert system
- **Regulatory Submission**: Coordinate FDA/EMA submissions
- **Follow-up Management**: Track ongoing event updates

### Documentation Management
- **Medical Records**: Link supporting clinical documentation
- **Laboratory Results**: Attach relevant lab values
- **Imaging Studies**: Reference diagnostic imaging
- **Autopsy Reports**: Document post-mortem findings when applicable
- **Source Document Verification**: Maintain data integrity

### Compliance Tracking
- **Deadline Monitoring**: Track 7/15-day reporting requirements
- **Submission Status**: Monitor regulatory filing status
- **Amendment Tracking**: Document report updates and corrections
- **Audit Trail**: Complete history of all reporting actions
- **IRB Notification**: Coordinate institutional review board reporting

## Contract Architecture

### Data Structures

**Serious Adverse Event**
- Patient identifier (anonymized)
- Event description and diagnosis
- Onset and resolution dates
- Seriousness criteria (death, life-threatening, hospitalization, disability, congenital anomaly, other)
- Severity grade (1-5 CTCAE scale)
- Expectedness classification
- Outcome status

**Causality Assessment**
- Relationship to study drug (unrelated, unlikely, possible, probable, definite)
- Naranjo score
- Assessing physician
- Assessment date
- Supporting rationale
- Alternative etiologies

**Expedited Report**
- Report ID and version
- Initial/follow-up designation
- Submission deadline (7 or 15 days)
- Report type (initial, follow-up, final)
- CIOMS form data
- Submission status
- Regulatory tracking numbers

**Sponsor Notification**
- Notification timestamp
- Recipient organization
- Notification method
- Acknowledgment receipt
- Escalation tracking

**Regulatory Submission**
- Submission date and time
- Regulatory authority (FDA, EMA, etc.)
- Submission method (electronic, paper)
- Confirmation number
- Acceptance status

## Core Functions

### Event Management
- `report-serious-adverse-event`: Document new SAE occurrence
- `update-event-outcome`: Record event resolution or ongoing status
- `classify-seriousness`: Assign seriousness criteria
- `grade-severity`: Apply CTCAE severity grading
- `assess-expectedness`: Determine if event is expected

### Causality Functions
- `perform-causality-assessment`: Document relationship determination
- `calculate-naranjo-score`: Standardized causality scoring
- `identify-alternative-causes`: Document confounding factors
- `update-causality`: Revise assessment with new information

### Reporting Functions
- `generate-expedited-report`: Create regulatory report
- `submit-to-sponsor`: Notify study sponsor
- `file-regulatory-submission`: Submit to authorities
- `send-followup-report`: Submit event updates
- `close-safety-report`: Finalize reporting for resolved event

### Compliance Functions
- `calculate-reporting-deadline`: Determine 7 or 15-day timeline
- `check-deadline-status`: Monitor submission timeliness
- `notify-irb`: Inform institutional review board
- `document-protocol-deviation`: Record any reporting delays
- `generate-compliance-report`: Audit trail summary

### Query Functions
- `get-event-details`: Retrieve SAE information
- `get-causality-assessment`: Access causality data
- `get-report-status`: Check submission status
- `get-pending-reports`: List overdue submissions
- `get-site-safety-summary`: Site-specific SAE statistics
- `get-study-safety-profile`: Overall trial safety data

## Access Control

### Roles
- **Contract Owner**: Principal Investigator or Safety Officer
- **Site Coordinators**: Report SAEs from clinical sites
- **Medical Reviewers**: Perform causality assessments
- **Regulatory Staff**: Submit reports to authorities
- **Sponsors**: Access safety data and reports
- **Auditors**: Read-only compliance verification

### Permissions
- Site Coordinators can report events and updates
- Medical Reviewers can perform causality assessments
- Regulatory Staff can generate and submit reports
- Sponsors have read access to all safety data
- Only Contract Owner can modify system settings

## Security Features

- **Patient Anonymization**: No PHI stored on blockchain
- **Role-Based Access**: Granular permission control
- **Immutable Records**: Permanent SAE documentation
- **Audit Trail**: Complete history of all actions
- **Deadline Enforcement**: Automatic compliance monitoring
- **Multi-Signature Approvals**: Critical actions require multiple confirmations

## Use Cases

### Immediate SAE Reporting
1. Site coordinator identifies serious adverse event
2. System automatically classifies seriousness criteria
3. Medical reviewer performs causality assessment
4. Report triggers sponsor notification
5. Regulatory deadline calculated and tracked
6. Expedited report generated and submitted

### Death Reporting
1. Death event flagged with highest priority
2. Immediate sponsor notification (24 hours)
3. Medical review of causality
4. 7-day expedited report prepared
5. Regulatory authorities notified
6. Follow-up reporting coordinated

### Unexpected Serious Event
1. Event identified that's not in investigator brochure
2. Marked as unexpected serious adverse reaction
3. Escalated reporting timeline triggered
4. Comprehensive causality review conducted
5. Safety signal assessment initiated
6. All sites notified of new safety information

### Multi-Site Coordination
1. SAE reported from multiple trial sites
2. Events aggregated for safety review
3. Pattern analysis identifies potential signal
4. Coordinated reporting to regulatory authorities
5. Protocol amendments considered
6. Investigator notification issued

## Benefits

### For Research Safety
- **Rapid Detection**: Immediate identification of serious events
- **Complete Documentation**: Comprehensive SAE records
- **Causality Transparency**: Clear relationship assessment
- **Compliance Assurance**: Deadline tracking prevents violations
- **Signal Detection**: Pattern identification across sites

### For Regulatory Compliance
- **Timely Reporting**: Automated deadline management
- **Accurate Documentation**: Standardized data collection
- **Audit Readiness**: Complete immutable records
- **ICH-GCP Alignment**: Follows international guidelines
- **Submission Tracking**: Monitor regulatory filing status

### For Patient Safety
- **Rapid Response**: Quick identification and reporting
- **Risk Mitigation**: Early safety signal detection
- **Transparency**: Clear documentation of adverse events
- **Continuous Monitoring**: Ongoing safety surveillance
- **Informed Consent Updates**: New safety information communicated

### For Sponsors and CROs
- **Real-Time Visibility**: Immediate access to safety data
- **Risk Management**: Proactive safety monitoring
- **Regulatory Confidence**: Compliant reporting processes
- **Multi-Study Analysis**: Aggregate safety data across trials
- **Investigator Support**: Streamlined reporting workflow

## Regulatory Compliance

### FDA Requirements
- 21 CFR 312.32: IND safety reporting
- 7-day reports for fatal/life-threatening unexpected events
- 15-day reports for serious unexpected events
- Annual safety reports

### EMA Requirements
- Directive 2001/20/EC compliance
- SUSAR reporting within required timelines
- Development Safety Update Reports (DSURs)
- Urgent safety measures documentation

### ICH-GCP Guidelines
- E2A: Clinical Safety Data Management
- E2B: Electronic Transmission of Safety Data
- E2D: Post-Approval Safety Data Management
- E2E: Pharmacovigilance Planning

## Deployment

This contract is built using Clarity for the Stacks blockchain, ensuring transparent and verifiable clinical trial safety reporting.

### Requirements
- Clarinet development environment
- Stacks wallet for contract deployment
- HIPAA-compliant data handling procedures
- IRB approval for blockchain data storage

### Installation
```bash
clarinet new clinical-trial-serious-adverse-event-reporting
cd clinical-trial-serious-adverse-event-reporting
clarinet contract new serious-event-reporter
clarinet check
clarinet test
```

## Testing

Comprehensive test coverage includes:
- SAE identification and classification
- Causality assessment workflows
- Reporting deadline calculations
- Sponsor notification functionality
- Regulatory submission tracking
- Compliance monitoring accuracy
- Access control verification
- Multi-site coordination scenarios

## Data Privacy

- **No PHI Storage**: Patient identifiers are anonymized codes only
- **HIPAA Compliance**: System designed for regulatory compliance
- **Access Logs**: All data access is recorded
- **Encryption**: Sensitive data encrypted off-chain
- **Right to Erasure**: Study IDs allow data removal if required

## Future Enhancements

- Integration with electronic data capture (EDC) systems
- Automated CIOMS form generation with pre-population
- Machine learning for causality prediction
- Real-time safety signal detection algorithms
- Multi-language support for international trials
- Mobile application for site coordinators
- Dashboard visualization for safety monitoring
- Integration with MedDRA coding for event classification

## License

MIT License

## Support

For questions or issues related to clinical trial safety reporting, please contact your institutional review board, study sponsor, or regulatory affairs department.

## Disclaimer

This system is designed to support, not replace, existing clinical trial safety reporting processes. All regulatory reporting must be reviewed and approved by qualified personnel before submission to authorities.
